LIPOPROTEIN(A) IN PATIENTS WITH CAROTID ATHEROSCLEROSIS AND ISCHEMIC CEREBROVASCULAR DISORDERS

被引:45
作者
JOVICIC, A [1 ]
IVANISEVIC, V [1 ]
IVANOVIC, I [1 ]
机构
[1] MIL MED ACAD, CLIN CHEM LAB, BELGRADE, YUGOSLAVIA
关键词
LIPOPROTEIN(A); CAROTID ATHEROSCLEROSIS; ISCHEMIC CEREBROVASCULAR DISORDERS;
D O I
10.1016/0021-9150(93)90223-H
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The aim of this study was to evaluate the role of lipoprotein(a) in the carotid atherosclerosis and ischemic cerebrovascular disorders. Four groups of subjects were included: 49 patients with transient ischemic attacks, 61 with acute cerebral infarction, 48 with asymptomatic carotid atherosclerosis and a group of 50 healthy subjects. Lipoprotein(a) serum concentration and its correlation with various clinical parameters was analysed. The results revealed a significant difference between lipoprotein(a) serum levels in patients and healthy subjects and positive correlation between lipoprotein(a) serum levels and the degree of carotid atherosclerosis. Moreover, some other correlations are found and discussed. It was concluded that lipoprotein(a) is involved in the pathogenesis of carotid atherosclerosis, but it is not associated with the development of ischemic cerebrovascular disorders.
引用
收藏
页码:59 / 65
页数:7
相关论文
共 24 条
[1]   LP(A) LIPOPROTEIN - RELATIONSHIP TO SINKING PRE-BETA LIPOPROTEIN, HYPERLIPOPROTEINEMIA, AND APOLIPOPROTEIN-B [J].
ALBERS, JJ ;
CABANA, VG ;
WARNICK, GR ;
HAZZARD, WR .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1975, 24 (09) :1047-1054
[2]  
AVOGARO P, 1979, LANCET, V1, P901
[3]  
BREWER HB, 1988, CLIN CHEM, V34, pB4
[4]  
BRUCK J, 1985, NERVENARZT, V56, P89
[5]   MANAGEMENT OF CAROTID-ARTERY OCCLUSION (REPRINTED FROM CURRENT CONCEPTS OF CEREBROVASCULAR-DISEASE AND STROKE, VOL 23, PG 25-29, 1988) [J].
COTE, R ;
CARON, JL .
STROKE, 1989, 20 (01) :123-126
[6]   DIFFERENCES IN MORTALITY AND CARDIOVASCULAR MORBIDITY DURING A 3-YEAR FOLLOW-UP OF TRANSIENT ISCHEMIC ATTACKS AND MINOR STROKES [J].
FALKE, P ;
STAVENOW, L ;
YOUNG, M ;
LINDGARDE, F .
STROKE, 1989, 20 (03) :340-344
[7]   LIPOPROTEINS, CARDIOVASCULAR-DISEASE, AND DEATH - THE FRAMINGHAM-STUDY [J].
GORDON, T ;
KANNEL, WB ;
CASTELLI, WP ;
DAWBER, TR .
ARCHIVES OF INTERNAL MEDICINE, 1981, 141 (09) :1128-1131
[8]   DOES PLATELET ANTIAGGREGANT THERAPY LESSEN THE SEVERITY OF STROKE [J].
GROTTA, JC ;
LEMAK, NA ;
GARY, H ;
FIELDS, WS ;
VITAL, D .
NEUROLOGY, 1985, 35 (05) :632-636
[9]  
JURGENS G, 1983, CLIN CHEM, V29, P1856
[10]   APOLIPOPROTEIN-A-I, APOLIPOPROTEIN-AII AND HDL PHOSPHOLIPIDS BUT NOT APO-B ARE RISK INDICATORS FOR OCCLUSIVE CEREBROVASCULAR-DISEASE [J].
KOSTNER, GM ;
MARTH, E ;
PFEIFFER, KP ;
WEGE, H .
EUROPEAN NEUROLOGY, 1986, 25 (05) :346-354